415 related articles for article (PubMed ID: 20493600)
1. Thrombopoietic agents.
Stasi R; Bosworth J; Rhodes E; Shannon MS; Willis F; Gordon-Smith EC
Blood Rev; 2010; 24(4-5):179-90. PubMed ID: 20493600
[TBL] [Abstract][Full Text] [Related]
2. New thrombopoietin receptor agonists for platelet disorders.
Homeida S; Ebdon C; Batty P; Jackson B; Kolade S; Bateman C; Peng YY; Stasi R
Drugs Today (Barc); 2012 Apr; 48(4):293-301. PubMed ID: 22536571
[TBL] [Abstract][Full Text] [Related]
3. The new thrombopoietic agenda: impact on leukemias and MDS.
Bussel JB
Best Pract Res Clin Haematol; 2014; 27(3-4):288-92. PubMed ID: 25455280
[TBL] [Abstract][Full Text] [Related]
4. Current status of thrombopoietic agents.
Rhodes E; Stasi R
Expert Rev Hematol; 2010 Apr; 3(2):217-25. PubMed ID: 21083464
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin receptor agonists in primary immune thrombocytopenia.
Siegal D; Crowther M; Cuker A
Semin Hematol; 2013 Jan; 50 Suppl 1(0 1):S18-21. PubMed ID: 23664510
[TBL] [Abstract][Full Text] [Related]
6. New thrombopoietic growth factors.
Kuter DJ
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S347-56. PubMed ID: 19778863
[TBL] [Abstract][Full Text] [Related]
7. What is the potential for thrombopoietic agents in acute leukemia?
Kuter DJ
Best Pract Res Clin Haematol; 2011 Dec; 24(4):553-8. PubMed ID: 22127320
[TBL] [Abstract][Full Text] [Related]
8. Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura.
Stasi R; Evangelista ML; Amadori S
Drugs; 2008; 68(7):901-12. PubMed ID: 18457458
[TBL] [Abstract][Full Text] [Related]
9. Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?
Sallmon H; Gutti RK; Ferrer-Marin F; Liu ZJ; Sola-Visner MC
J Perinatol; 2010 Dec; 30(12):765-9. PubMed ID: 20410910
[TBL] [Abstract][Full Text] [Related]
10. The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia.
Levy B; Arnason JE; Bussel JB
Curr Opin Oncol; 2008 Nov; 20(6):690-6. PubMed ID: 18841052
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin receptor agonists in hereditary thrombocytopenias.
Rodeghiero F; Pecci A; Balduini CL
J Thromb Haemost; 2018 Sep; 16(9):1700-1710. PubMed ID: 29956472
[TBL] [Abstract][Full Text] [Related]
12. Moving towards a new era in the management of chronic immune thrombocytopenia.
Wadenvik H; Olsson B
Ann Hematol; 2010 Jul; 89 Suppl 1():87-93. PubMed ID: 20339846
[TBL] [Abstract][Full Text] [Related]
13. The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
Mazza P; Minoia C; Melpignano A; Polimeno G; Cascavilla N; Di Renzo N; Specchia G
Ann Hematol; 2016 Jan; 95(2):239-44. PubMed ID: 26596973
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin-receptor agonists for primary immune thrombocytopenia.
Imbach P; Crowther M
N Engl J Med; 2011 Aug; 365(8):734-41. PubMed ID: 21864167
[No Abstract] [Full Text] [Related]
15. Thrombopoietin mimetics for patients with myelodysplastic syndromes.
Dodillet H; Kreuzer KA; Monsef I; Skoetz N
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009883. PubMed ID: 28962071
[TBL] [Abstract][Full Text] [Related]
16. Biologic aspects of thrombopoietin and the development of novel thrombopoietic agents for clinical use.
Evangelista ML; Amadori S; Stasi R
Curr Drug Discov Technol; 2007 Oct; 4(3):162-73. PubMed ID: 17985999
[TBL] [Abstract][Full Text] [Related]
17. Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents.
Vadhan-Raj S
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S26-32. PubMed ID: 19245931
[TBL] [Abstract][Full Text] [Related]
18. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia.
Kuter DJ
Annu Rev Med; 2009; 60():193-206. PubMed ID: 19642221
[TBL] [Abstract][Full Text] [Related]
19. Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center.
González KJ; Zuluaga SO; DaRos CV; Rodríguez PP; Martí AC
Ann Hematol; 2017 Mar; 96(3):507-508. PubMed ID: 27975127
[No Abstract] [Full Text] [Related]
20. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
Mitchell WB; Pinheiro MP; Boulad N; Kaplan D; Edison MN; Psaila B; Karpoff M; White MJ; Josefsson EC; Kile BT; Bussel JB
Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
